Sodium-glucose cotransporter 2 inhibitors for wild-type transthyretin amyloidosis: Insights from a global database.

Zathar Z, Wilson DG

Open source

DOI
10.1016/j.ahjo.2025.100625
Published
2025 Dec
Container
American heart journal plus : cardiology research and practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ahjo.2025.100625,
  title = {Sodium-glucose cotransporter 2 inhibitors for wild-type transthyretin amyloidosis: Insights from a global database.},
  author = {Zathar Z and Wilson DG},
  year = {2025},
  journal = {American heart journal plus : cardiology research and practice},
  doi = {10.1016/j.ahjo.2025.100625},
  url = {https://doi.org/10.1016/j.ahjo.2025.100625}
}

RIS

TY  - JOUR
TI  - Sodium-glucose cotransporter 2 inhibitors for wild-type transthyretin amyloidosis: Insights from a global database.
AU  - Zathar Z
AU  - Wilson DG
PY  - 2025
JO  - American heart journal plus : cardiology research and practice
DO  - 10.1016/j.ahjo.2025.100625
UR  - https://doi.org/10.1016/j.ahjo.2025.100625
ER  - 

APA

Z, Z., & DG, W. (2025). Sodium-glucose cotransporter 2 inhibitors for wild-type transthyretin amyloidosis: Insights from a global database.. American heart journal plus : cardiology research and practice. https://doi.org/10.1016/j.ahjo.2025.100625

Source records